Hemodynamic effects and clinical determinants of defibrillation threshold for transvenous atrial defibrillation using biatrial biphasic shocks in patients with chronic atrial fibrillation

PACE - Pacing and Clinical Electrophysiology

Volumn 20, Issue 4 I, 1997, Pages 899-908

  Lok, Ngai Sang ^a   Lau, Chu Pak ^a   Ho, David Sai Wah ^a   Tang, Yuen Wai ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

clinical predictors; defibrillation threshold; transvenous atrial defibrillation

Indexed keywords

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD CLOT LYSIS; BLOOD PRESSURE REGULATION; CARDIOVERSION; CLINICAL ARTICLE; DEFIBRILLATION; FEMALE; HEART ATRIUM FIBRILLATION; HEMODYNAMICS; HUMAN; MALE; PREDICTION; SHOCK WAVE; SINUS RHYTHM;

EID: 0030981413     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1997.tb05492.x     Document Type: Article

References (22)

1. Gosselink ATM, Bulsma EB, Landsman LJ, et al. Long-term effect of cardioversion on peak oxygen consumption in chronic atrial fibrillation: A 2-year follow-up. Eur Heart J 1994; 15:1368-1372.
2. Borgeat A, Goy JJ, Maendly R, et al. Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm. Am J Cardiol 1986; 58:496-498.
3. Zehender M, Hohnloser S, Muller B, et al. Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation: Results of a comparative study and a 2-year follow-up. J Am Coll Cardiol 1992; 19:1054-1059.
4. Levy S, Lauribe P, Dolla E, et al. A randomized comparison of external and internal cardioversion of chronic atrial fibrillation. Circulation 1992; 86: 1415-1420.
5. Kumagai K, Yamanouchi Y, Tashiro N, et al. Low energy synchronous transcatheter cardioversion of atrial flutter/fibrillation in the dog. J Am Coll Cardiol 1990; 16:497-450.
6. Cooper RAS, Alferness CA, Smith WM, et al. Internal cardioversion of atrial fibrillation in sheep. Circulation 1993; 87:1673-1686.
7. Murgatroyd FD, Slade AKB, Sopher SM, et al. Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. J Am Coll Cardiol 1995; 25:1347-1353.
8. Alt E, Conenen M, Schmitt C, et al. Intracardiac electrical conversion of atrial fibrillation: Which energies should be used? (abstract) Circulation 1994; 90(II):I-14.
9. Keane D, Sulke N, Cooke R, et al. Endocardial cardioversion of atrial flutter and fibrillation, (abstract) PACE 1993; 16(II):313.
10. Alt E, Schmitt C, Ammer R, et al. Initial experience with intracardiac atrial defibrillation in patients with chronic atrial fibrillation. PACE 1994; 17: 1067-1078.
11. Lok NS, Lau CP, Tang YW, et al. Effect of sotalol on transvenous atrial defibrillation for acute and chronic atrial fibrillation, (abstract) J Am Coll Cardiol 1995; 18:109A.
12. Niwano S, Sokoloski MC, Ortiz J, et al. Effects of digoxin and sotalol on atrial defibrillation thresholds via implanted transvenous catheter electrodes. (abstract) J Am Coll Cardiol 1995; 18:109A.
13. Martin D, Mendelsohn ME, John RM, et al. Cardioversion and other nonpharmacologic therapies. In: Atrial Fibrillation. London, UK, Blackwell Scientific Publications, 1994, pp. 43-59.
14. VanGelder IC, Crijns HJ, VanGilst WH, et al. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 1991; 68:41-46.
15. Dalzell GW, Anderson J, Adgey AA. Factors determining success and energy requirements for cardioversion of atrial fibrillation. Q J Med 1990; 76: 903-913.
16. Dittrich HC, Erickson JS, Schneiderman T, et al. Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol 1989; 63:193-197.
17. Brodsky MA, Allen BJ, Capparelli EV, et al. Factors determining maintenance of sinus rhythm after chronic: atrial fibrillation with left atrial dilatation. Am J Cardiol 1989; 63:1065-1068.
18. Waris E, Kreus KE, Salokannel J. Factors influencing persistence of sinus rhythm after DC shock treatment of atrial fibrillation. Acta Mod Scand 1971; 189:161-166.
19. VanGelder I, Crijins HJM, Hilege H, et al. Value and limitations of DC electrical cardioversion of chronic atrial fibrillation. (abstract) PACE 1995; 18:11-10.
20. Petersen P, Kastrup J, Brinch K, et al. Relation between left atrial dimension and duration of atrial fibrillation. Am J Cardiol 1987; 60:382-384.
21. Gosselink ATM, Crijns HJGM, Hamer HPM, et al. Changes in left and right atrial size after cardioversion of atrial fibrillation: Role of mitral valve disease. J Am Coll Cardiol 1993; 22:1666-1672.
22. Levy S, Lacombe P, Gointe R. High energy transcatheter cardioversion of chronic atrial fibrillation. J Am Coll Cardiol 1988; 12:514-518.